Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.43 CAD | +0.95% | -.--% | +2.06% |
May. 23 | Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director | CI |
May. 21 | Extendicare Price Target Raised to $8.50 at RBC | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 752.2 | 594.5 | 653.8 | 561 | 605.6 | 619.5 | - | - |
Enterprise Value (EV) 1 | 752.2 | 594.5 | 653.8 | 561 | 605.6 | 619.5 | 619.5 | 619.5 |
P/E ratio | - | - | - | - | - | - | - | - |
Yield | 5.69% | 7.23% | 6.58% | 7.32% | 6.59% | 6.46% | 10.9% | 33.4% |
Capitalization / Revenue | 0.66 x | 0.51 x | 0.54 x | 0.46 x | 0.46 x | 0.43 x | 0.43 x | 0.42 x |
EV / Revenue | 0.66 x | 0.51 x | 0.54 x | 0.46 x | 0.46 x | 0.43 x | 0.43 x | 0.42 x |
EV / EBITDA | 8.26 x | 4.47 x | 6.96 x | 9.76 x | 6.36 x | 6.04 x | 6.06 x | 5.93 x |
EV / FCF | 62.7 x | 6.74 x | -107 x | -47.4 x | -8.4 x | -62 x | 620 x | - |
FCF Yield | 1.6% | 14.8% | -0.93% | -2.11% | -11.9% | -1.61% | 0.16% | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 89,123 | 89,539 | 89,562 | 85,514 | 83,191 | 83,384 | - | - |
Reference price 2 | 8.440 | 6.640 | 7.300 | 6.560 | 7.280 | 7.430 | 7.430 | 7.430 |
Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 3/2/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 1,132 | 1,158 | 1,217 | 1,222 | 1,305 | 1,432 | 1,441 | 1,484 |
EBITDA 1 | 91.11 | 133.1 | 93.92 | 57.45 | 95.19 | 102.5 | 102.3 | 104.5 |
EBIT | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 12 | 88.16 | -6.099 | -11.83 | -72.14 | -10 | 1 | - |
FCF margin | 1.06% | 7.61% | -0.5% | -0.97% | -5.53% | -0.7% | 0.07% | - |
FCF Conversion (EBITDA) | 13.17% | 66.22% | - | - | - | - | 0.98% | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | 0.4800 | 0.4800 | 0.4800 | 0.4800 | 0.4800 | 0.4800 | 0.8133 | 2.480 |
Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 3/2/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 319.4 | 305.7 | 296.6 | 308.9 | 310.4 | 324.7 | 307.5 | 322.5 | 350.2 | 367.1 | 346.8 | 363.9 | 372.4 | 359.8 | 363.6 |
EBITDA 1 | 27.73 | 19.56 | 17.1 | 10.03 | 9.16 | - | - | 20.77 | - | - | 23.02 | 24.63 | 24.54 | 24.9 | 23.3 |
EBIT | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share 2 | 0.1200 | - | - | - | - | - | - | - | - | - | 0.1200 | 0.1200 | 0.1200 | - | - |
Announcement Date | 2/24/22 | 5/12/22 | 8/9/22 | 11/10/22 | 3/2/23 | 5/4/23 | 8/10/23 | 11/9/23 | 3/7/24 | 5/15/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 12 | 88.2 | -6.1 | -11.8 | -72.1 | -10 | 1 | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 2/27/20 | 2/25/21 | 2/24/22 | 3/2/23 | 3/7/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.06% | 454M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+70.11% | 13.09B | |
+79.20% | 13.21B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- EXE Stock
- Financials Extendicare Inc.